{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:18:48Z","timestamp":1789586328230,"version":"build-2803163510"},"reference-count":49,"publisher":"Wiley","issue":"17","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Austrian Science Funds (FWF)","award":["P21296"],"award-info":[{"award-number":["P21296"]}]},{"name":"Austrian Science Funds (FWF)","award":["P22771"],"award-info":[{"award-number":["P22771"]}]},{"name":"Austrian Science Funds (FWF)","award":["P25633"],"award-info":[{"award-number":["P25633"]}]},{"name":"DK Molecular Enzymology","award":["W901-B05 DK"],"award-info":[{"award-number":["W901-B05 DK"]}]}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:sec><jats:title>Background and Purpose<\/jats:title><jats:p>Monoglyceride lipase (<jats:styled-content style=\"fixed-case\">MGL<\/jats:styled-content>) degrades 2\u2010arachidonoyl glycerol (2\u2010<jats:styled-content style=\"fixed-case\">AG<\/jats:styled-content>), an endogenous agonist of cannabinoid receptors (<jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content><jats:sub>1\/2<\/jats:sub>). Because the <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content><jats:sub>1<\/jats:sub> receptor is involved in the control of gut function, we investigated the effects of pharmacological inhibition and genetic deletion of <jats:styled-content style=\"fixed-case\">MGL<\/jats:styled-content> on intestinal motility. Furthermore, we determined whether defective 2\u2010<jats:styled-content style=\"fixed-case\">AG<\/jats:styled-content> degradation affects \u03bc\u2010opioid receptor (\u03bc receptor) signalling, a parallel pathway regulating gut motility.<\/jats:p><\/jats:sec><jats:sec><jats:title>Experimental Approach<\/jats:title><jats:p>Gut motility was investigated by monitoring <jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>vans <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>lue transit and colonic bead propulsion in response to <jats:styled-content style=\"fixed-case\">MGL<\/jats:styled-content> inhibition and <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content><jats:sub>1<\/jats:sub> receptor or \u03bc receptor stimulation. Ileal contractility was investigated by electrical field stimulation. <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content><jats:sub>1<\/jats:sub> receptor expression in ileum and colon was assessed by immunohistochemical analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key Results<\/jats:title><jats:p>Pharmacological inhibition of <jats:styled-content style=\"fixed-case\">MGL<\/jats:styled-content> slowed down whole gut transit in a <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content><jats:sub>1<\/jats:sub> receptor\u2010dependent manner. Conversely, genetic deletion of <jats:styled-content style=\"fixed-case\">MGL<\/jats:styled-content> did not affect gut transit despite increased 2\u2010<jats:styled-content style=\"fixed-case\">AG<\/jats:styled-content> levels. Notably, <jats:styled-content style=\"fixed-case\">MGL<\/jats:styled-content> deficiency caused complete insensitivity to <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content><jats:sub>1<\/jats:sub> receptor agonist\u2010mediated inhibition of whole gut transit and ileal contractility suggesting local desensitization of <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content><jats:sub>1<\/jats:sub> receptors. Accordingly, immunohistochemical analyses of myenteric ganglia of <jats:styled-content style=\"fixed-case\">MGL<\/jats:styled-content>\u2010deficient mice revealed that <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content><jats:sub>1<\/jats:sub> receptors were trapped in endocytic vesicles. Finally, <jats:styled-content style=\"fixed-case\">MGL<\/jats:styled-content>\u2010deficient mice displayed accelerated colonic propulsion and were hypersensitive to \u03bc receptor agonist\u2010mediated inhibition of colonic motility. This phenotype was reproduced by chronic pharmacological inhibition of <jats:styled-content style=\"fixed-case\">MGL<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion and Implications<\/jats:title><jats:p>Constantly elevated 2\u2010<jats:styled-content style=\"fixed-case\">AG<\/jats:styled-content> levels induce severe desensitization of intestinal <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content><jats:sub>1<\/jats:sub> receptors and increased sensitivity to \u03bc receptor\u2010mediated inhibition of colonic motility. These changes should be considered when cannabinoid\u2010based drugs are used in the therapy of gastrointestinal diseases.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bph.13224","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T09:55:41Z","timestamp":1434362141000},"page":"4419-4429","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic \u03bc\u2010opioid receptor sensitivity"],"prefix":"10.1111","volume":"172","author":[{"given":"U","family":"Taschler","sequence":"first","affiliation":[{"name":"Institute of Molecular Biosciences University of Graz  Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T O","family":"Eichmann","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biosciences University of Graz  Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F P W","family":"Radner","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biosciences University of Graz  Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G F","family":"Grabner","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biosciences University of Graz  Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Wolinski","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biosciences University of Graz  Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Storr","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Gastroenterology Ludwig Maximilians University of Munich  Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lass","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biosciences University of Graz  Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Schicho","sequence":"additional","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology Medical University of Graz  Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biosciences University of Graz  Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12445"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12451"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-176602"},{"issue":"1","key":"e_1_2_10_5_1","first-page":"81","article-title":"Cannabinoids and gastrointestinal motility: animal and human studies","volume":"12","author":"Aviello G","year":"2008","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01644.x"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13114"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M710300200"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.018"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706824"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.110.068304"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01555-0"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.10270"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2008.05336.x"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(95)02053-5"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(93)90486-G"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00089a018"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02648.x"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.90285.2008"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.90500.2008"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01369.x"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.48.113006.094830"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.5.1932"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.08244FP"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2009.03.012"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2009.12.005"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/PL00005325"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703265"},{"key":"e_1_2_10_29_1","article-title":"Time course of isolated rat fundus response to muscarinic agonists: a measure of intrinsic efficacy","author":"Jankovic S","year":"1998","journal-title":"Physiol Res"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.19-10-03773.1999"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00872.x"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.175778"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.03.029"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.129"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.25.040185.001341"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00873.x"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)00109-D"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/365061a0"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1143"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.48.6.859"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.05.042"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706757"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2616"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.07.036"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1995.2437"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.215434"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706971"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.112.005942"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707486"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.10.5780"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbph.13224","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbph.13224","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bph.13224","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bph.13224","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bph.13224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T19:35:35Z","timestamp":1696361735000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bph.13224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":49,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.1111\/bph.13224"],"URL":"https:\/\/doi.org\/10.1111\/bph.13224","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]},"assertion":[{"value":"2015-02-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-06-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-07-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}